JP2009538276A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538276A5
JP2009538276A5 JP2009507606A JP2009507606A JP2009538276A5 JP 2009538276 A5 JP2009538276 A5 JP 2009538276A5 JP 2009507606 A JP2009507606 A JP 2009507606A JP 2009507606 A JP2009507606 A JP 2009507606A JP 2009538276 A5 JP2009538276 A5 JP 2009538276A5
Authority
JP
Japan
Prior art keywords
deoxynojirimycin
pentane
neopentyloxy
methoxy
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009507606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538276A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2007/050177 external-priority patent/WO2007123403A1/en
Publication of JP2009538276A publication Critical patent/JP2009538276A/ja
Publication of JP2009538276A5 publication Critical patent/JP2009538276A5/ja
Ceased legal-status Critical Current

Links

JP2009507606A 2006-04-24 2007-04-24 嚢胞性線維症の改良型治療 Ceased JP2009538276A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79408806P 2006-04-24 2006-04-24
PCT/NL2007/050177 WO2007123403A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Publications (2)

Publication Number Publication Date
JP2009538276A JP2009538276A (ja) 2009-11-05
JP2009538276A5 true JP2009538276A5 (enExample) 2010-04-08

Family

ID=38283020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507606A Ceased JP2009538276A (ja) 2006-04-24 2007-04-24 嚢胞性線維症の改良型治療

Country Status (10)

Country Link
US (1) US8410081B2 (enExample)
EP (1) EP2010551B1 (enExample)
JP (1) JP2009538276A (enExample)
CN (1) CN101479288B (enExample)
AT (1) ATE479696T1 (enExample)
AU (1) AU2007241622A1 (enExample)
BR (1) BRPI0710883A2 (enExample)
CA (1) CA2650311A1 (enExample)
DE (1) DE602007008870D1 (enExample)
WO (1) WO2007123403A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712494D0 (en) 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
JP5600329B2 (ja) 2009-02-23 2014-10-01 ユナイテッド セラピューティクス コーポレーション イミノ糖およびウイルス性疾患を治療する方法
KR101787434B1 (ko) * 2009-02-24 2017-11-15 유나이티드 세러퓨틱스 코오포레이션 이미노슈가 및 아레나바이러스성 감염을 치료하는 방법
JP5634510B2 (ja) 2009-06-12 2014-12-03 ユナイテッド セラピューティクス コーポレイション イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
KR101459530B1 (ko) * 2009-09-04 2014-11-07 유나이티드 세러퓨틱스 코오포레이션 폭스바이러스 감염의 치료 방법
KR101497194B1 (ko) * 2009-09-04 2015-02-27 유나이티드 세러퓨틱스 코오포레이션 오르토믹소바이러스 감염의 치료 방법
JP5752689B2 (ja) * 2009-09-04 2015-07-22 ユナイテッド セラピューティクス コーポレイション フィロウイルス疾患を治療するイミノ糖および方法
GB201000499D0 (en) 2010-01-13 2010-03-03 Fleet George W J Treatment of cystic fibrosis
WO2011095772A2 (en) 2010-02-04 2011-08-11 Summit Corporation Plc Novel iminosugar therapeutics
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
EP3741384A1 (en) 2011-09-07 2020-11-25 Mount Sinai School Of Medicine Ceramidase and cell differentiation
CN109529028A (zh) 2012-06-01 2019-03-29 西奈山伊坎医学院 在感染的治疗和预防中的神经酰胺水平
US20150346185A1 (en) * 2012-12-05 2015-12-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Diagnosis of cystic fibrosis
WO2014160390A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Therapeutic acid ceramidase compositions and methods of making and using them
WO2017178499A1 (en) 2016-04-11 2017-10-19 Spedding Research Solutions Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
RS67675B1 (sr) 2017-06-01 2026-02-27 Idorsia Pharmaceuticals Ltd Kristalni oblik n‐butildeoksigalaktonojirimicina
BR112023018404A2 (pt) * 2021-03-12 2023-11-28 Excepgen Inc Sistemas e métodos para expressão de proteína

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002161A1 (en) 1996-07-15 1998-01-22 Universiteit Van Amsterdam Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
AU5799500A (en) * 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
FR2861991B1 (fr) * 2003-11-07 2008-01-18 Centre Nat Rech Scient Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose
WO2005123055A2 (en) * 2004-06-14 2005-12-29 Musc Foundation For Research Development Methods for treating inflammatory disorders
CA2616537A1 (en) 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof

Similar Documents

Publication Publication Date Title
JP2004519469A5 (enExample)
JP2004538303A5 (enExample)
JP2011513196A5 (enExample)
JP2010504343A5 (enExample)
JP2007016035A5 (enExample)
JP2006526590A5 (enExample)
JP2009535370A5 (enExample)
JP2007514005A5 (enExample)
JP2007501251A5 (enExample)
JP2007529532A5 (enExample)
JP2012502885A5 (enExample)
JP2010526840A5 (enExample)
JP2009500423A5 (enExample)
WO2009064374A8 (en) Oral formulations of bis(thiohydrazide amides)
ES2489265T3 (es) Asociación de inhibidores de la HMG-CoA reductasa atorvastatina o simvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast para el tratamiento de enfermedades pulmonares inflamatorias
WO2011106688A1 (en) Bis-fatty acid conjugates and their uses
JP2000159790A5 (enExample)
JP2005508963A5 (enExample)
RU2009119567A (ru) Уменьшение избыточной массы тела или ожирения
SE0401655D0 (sv) New compounds
JP2011068692A5 (enExample)
JP2022529814A5 (enExample)
EA200500240A1 (ru) Новый способ синтеза соединений 1,3,4,5-тетрагидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
JP2010533717A5 (enExample)
JP2007507472A5 (enExample)